Weight-Loss Drug Zepbound Faces Supply Issues
Another popular weight-loss drug is in short supply. Doses of tirzepatide (Zepbound) are few and far between, experts told MedPage Today, although the injectable has not been listed in the FDA Drug Shortage Database as of today. Another version of tirzepatide, for type 2 diabetes (Mounjaro), has been on the FDA shortage list since December […]
Potential strategy for fighting obesity: Lab safely replicates weight-loss benefits of plant linked to harmful side effects
UT Southwestern scientists may have identified a method of safely mimicking the weight-loss benefits of a plant compound that — despite its harmful side effects — hold critical answers to developing therapies for obesity. Celastrol, derived from the root extracts of a white-flowered plant in China, has drawn increased attention in recent years after studies […]
Meds, surgery may help obesity-related high blood pressure if diet, exercise fall short
Weight-loss medications and surgical procedures show promise for reducing the long-term effects of high blood pressure (also called hypertension) in people who are overweight or have obesity, according to a new American Heart Association scientific statement published today in the Association’s journal Hypertension. A scientific statement is an expert analysis of current research and may […]
Common weight-loss drug successfully targets fat that can endanger heart health
Researchers at UT Southwestern announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide. In adults who are overweight or have obesity combined with high cardiovascular risk, once-daily liraglutide combined with lifestyle interventions significantly lowered two types of fat that have been associated with risk to heart health: visceral fat […]